ESMO 2022 Conference Coverage

 

ESMO 2022 Conference Coverage
Avatar

Lecture Summary - ESMO 2022 on the NuTide:302 Study: NUC-3373, a ProTide Transformation of 5-FI, in Combination with Oxaliplatin (NUFOX) or Irinotecan (NUFIRI) in Advanced CRC

By ESMO 2022 Conference Coverage FEATURING Andrew Coveler
By ESMO 2022 Conference Coverage FEATURING Andrew Coveler
14 views
October 3, 2022
Comments 0
Login to view comments. Click here to Login
GI
07:10

ESMO 2022 on ctDNA Dynamics, CEA, and Sites of Recurrence for the Ra…

ESMO 2022 Conference Coverage

J. Tie

448 views
01:21

Lecture Summary - ESMO 2022 on Characterizing the Clinico-Genomic La…

ESMO 2022 Conference Coverage

F. Keane

18 views
05:27

ESMO 2022 on Characterizing the Clinico-Genomic Landscape and Outcom…

ESMO 2022 Conference Coverage

F. Keane

60 views
01:01

Lecture Summary - ESMO 2022 on the NuTide:302 Study: NUC-3373, a Pro…

ESMO 2022 Conference Coverage

A. Coveler

14 views
04:14

ESMO 2022 on the NuTide:302 Study: NUC-3373, a ProTide Transformatio…

ESMO 2022 Conference Coverage

A. Coveler

73 views
09:14

ESMO 2022 on the Global Phase 3 Multiregional Clinical Trial FRESCO-…

ESMO 2022 Conference Coverage

A. Dasari

254 views
06:14

ESMO 2022 on the Phase 3 HIMALAYA Study: Impact of Viral Aetiology o…

ESMO 2022 Conference Coverage

S. L. Chan

79 views
12:50

ESMO 2022 on KRYSTAL-1: Updated Efficacy & Safety of Adagrasib With/…

ESMO 2022 Conference Coverage

S. Klempner

206 views
43

Lecture Summary - ESMO 2022 on the Global Phase 3 Multiregional Clin…

ESMO 2022 Conference Coverage

A. Dasari

13 views
42

Lecture Summary - ESMO 2022 on the Updated Analysis of DESTINY-Gastr…

ESMO 2022 Conference Coverage

G. Ku

9 views
05:29

ESMO 2022 Updated Analysis of DESTINY-Gastric02 Trial: T-DXd in West…

ESMO 2022 Conference Coverage

G. Ku

188 views
01:26

Lecture Summary - ESMO 2022 on the Phase III ERMES Study: FOLFIRI/Ce…

ESMO 2022 Conference Coverage

A. Orlandi

24 views
12:14

ESMO 2022 on the Phase III ERMES Study: FOLFIRI/Cetuximab vs. FOLFIR…

ESMO 2022 Conference Coverage

A. Orlandi

219 views
03:47

ESMO 2022: Early Decreases in KRAS Mutant Allele Frequency Predicts …

ESMO 2022 Conference Coverage

H. Lenz

58 views
01:35

Lecture Summary - ESMO 2022: Beyond 1L for mCRC - Best Practices and…

ESMO 2022 Conference Coverage

T. Price

18 views
20:07

Beyond 1L for mCRC - Best Practices and Practical Nuances

Timothy Price

311 views
16:12

ESMO 2022 on Advances in HER2-Targeted Therapy or Novel Targeted The…

ESMO 2022 Conference Coverage

K. Shitara

277 views
18

Lecture Summary - ESMO 2022: Real-World Monitoring of ctDNA Reliably…

ESMO 2022 Conference Coverage

S. Cohen

17 views
05:42

ESMO 2022: Real-World Monitoring of ctDNA Reliably Predicts Cancer R…

ESMO 2022 Conference Coverage

S. Cohen

330 views
09:24

ESMO 2022 Final Analysis of the Randomized, Phase 3 RATIONALE-301 St…

ESMO 2022 Conference Coverage

M. Kudo

104 views
04:44

ESMO 2022 on the Updated OS From the Phase 3 TOPAZ-1 Study: Durvalum…

ESMO 2022 Conference Coverage

D. Oh

167 views
46

Lecture Summary - ESMO 2022 on 4.5-Year Follow-Up From KEYNOTE-240: …

ESMO 2022 Conference Coverage

J. Edeline

10 views
04:28

ESMO 2022 on 4.5-Year Follow-Up From KEYNOTE-240: Pembrolizumab vs. …

ESMO 2022 Conference Coverage

J. Edeline

122 views
13:16

ESMO 2022 on the NICHE-2 Study: Neoadjuvant Immune Checkpoint Inhibi…

ESMO 2022 Conference Coverage

M. Chalabi

919 views
19

Lecture Summary - ESMO 2022 on the HIPECT4 Randomized Phase 3 Study:…

ESMO 2022 Conference Coverage

A. Arjona-Sanchez

22 views
05:02

ESMO 2022 on the HIPECT4 Randomized Phase 3 Study: Adjuvant Hyperthe…

ESMO 2022 Conference Coverage

A. Arjona-Sanchez

855 views
22

Lecture Summary - ESMO 2022 on the SAMCO-PRODIGE 54 Randomised Phase…

ESMO 2022 Conference Coverage

J. Taieb

10 views
06:19

ESMO 2022 on the SAMCO-PRODIGE 54 Randomised Phase II Trial: Aveluma…

ESMO 2022 Conference Coverage

J. Taieb

216 views